SRY and architectural gene regulation: The kinetic stability of a bent protein-DNA complex can regulate its transcriptional potency

Etsuji Ukiyama, Agnes Jancso-Radek, Biaoru Li, Lukasz Milos, Wei Zhang, Nelson B. Phillips, Nobuyuki Morikawa, Chin Yen King, Ging Chan, Christopher M. Haqq, James T. Radek, Francis Poulat, Patricia K. Donahoe, Michael A. Weiss

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Protein-directed DNA bending is proposed to regulate assembly of higher-order DNA-multiprotein complexes (enhanceosomes and repressosomes). Because transcriptional initiation is a nonequilibrium process, gene expression may be modulated by the lifetime of such complexes. The human testis-determining factor SRY contains a specific DNA-bending motif, the high-mobility group (HMG) box, and is thus proposed to function as an architectural factor. Here, we test the hypothesis that the kinetic stability of a bent HMG box-DNA complex can in itself modulate transcriptional potency. Our studies employ a cotransfection assay in a mammalian gonadal cell line as a model for SRY-dependent transcriptional activation. Whereas sex-reversal mutations impair SRY-dependent gene expression, an activating substitution is identified that enhances SRY's potency by 4-fold. The substitution (l13F in the HMG box; fortuitously occurring in chimpanzees) affects the motif's cantilever side chain, which inserts between base pairs to disrupt base pairing. An aromatic F13 cantilever prolongs the lifetime of the DNA complex to an extent similar to its enhanced function. By contrast, equilibrium properties (specific DNA affinity, specificity, and bending; thermodynamic stability and cellular expression) are essentially unchanged. This correlation between potency and lifetime suggests a mechanism of kinetic control. We propose that a locked DNA bend enables multiple additional rounds of transcriptional initiation per promoter. This model predicts the occurrence of a novel class of clinical variants, bent but unlocked HMG box-DNA complexes with native affinity and decreased lifetime. Aromatic DNA-intercalating agents exhibit analogous kinetic control of transcriptional elongation whereby chemotherapeutic potencies correlate with drug-DNA dissociation rates.

Original languageEnglish (US)
Pages (from-to)363-377
Number of pages15
JournalMolecular Endocrinology
Volume15
Issue number3
DOIs
StatePublished - Jan 1 2001
Externally publishedYes

Fingerprint

DNA
Genes
Proteins
Base Pairing
Sex-Determining Region Y Protein
Intercalating Agents
Gene Expression
Multiprotein Complexes
Nucleotide Motifs
Pan troglodytes
Thermodynamics
Transcriptional Activation
Cell Line
Mutation
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology

Cite this

SRY and architectural gene regulation : The kinetic stability of a bent protein-DNA complex can regulate its transcriptional potency. / Ukiyama, Etsuji; Jancso-Radek, Agnes; Li, Biaoru; Milos, Lukasz; Zhang, Wei; Phillips, Nelson B.; Morikawa, Nobuyuki; King, Chin Yen; Chan, Ging; Haqq, Christopher M.; Radek, James T.; Poulat, Francis; Donahoe, Patricia K.; Weiss, Michael A.

In: Molecular Endocrinology, Vol. 15, No. 3, 01.01.2001, p. 363-377.

Research output: Contribution to journalArticle

Ukiyama, E, Jancso-Radek, A, Li, B, Milos, L, Zhang, W, Phillips, NB, Morikawa, N, King, CY, Chan, G, Haqq, CM, Radek, JT, Poulat, F, Donahoe, PK & Weiss, MA 2001, 'SRY and architectural gene regulation: The kinetic stability of a bent protein-DNA complex can regulate its transcriptional potency', Molecular Endocrinology, vol. 15, no. 3, pp. 363-377. https://doi.org/10.1210/mend.15.3.0621
Ukiyama, Etsuji ; Jancso-Radek, Agnes ; Li, Biaoru ; Milos, Lukasz ; Zhang, Wei ; Phillips, Nelson B. ; Morikawa, Nobuyuki ; King, Chin Yen ; Chan, Ging ; Haqq, Christopher M. ; Radek, James T. ; Poulat, Francis ; Donahoe, Patricia K. ; Weiss, Michael A. / SRY and architectural gene regulation : The kinetic stability of a bent protein-DNA complex can regulate its transcriptional potency. In: Molecular Endocrinology. 2001 ; Vol. 15, No. 3. pp. 363-377.
@article{b0a461ef2b6048ba87d7b25ce84e2f4a,
title = "SRY and architectural gene regulation: The kinetic stability of a bent protein-DNA complex can regulate its transcriptional potency",
abstract = "Protein-directed DNA bending is proposed to regulate assembly of higher-order DNA-multiprotein complexes (enhanceosomes and repressosomes). Because transcriptional initiation is a nonequilibrium process, gene expression may be modulated by the lifetime of such complexes. The human testis-determining factor SRY contains a specific DNA-bending motif, the high-mobility group (HMG) box, and is thus proposed to function as an architectural factor. Here, we test the hypothesis that the kinetic stability of a bent HMG box-DNA complex can in itself modulate transcriptional potency. Our studies employ a cotransfection assay in a mammalian gonadal cell line as a model for SRY-dependent transcriptional activation. Whereas sex-reversal mutations impair SRY-dependent gene expression, an activating substitution is identified that enhances SRY's potency by 4-fold. The substitution (l13F in the HMG box; fortuitously occurring in chimpanzees) affects the motif's cantilever side chain, which inserts between base pairs to disrupt base pairing. An aromatic F13 cantilever prolongs the lifetime of the DNA complex to an extent similar to its enhanced function. By contrast, equilibrium properties (specific DNA affinity, specificity, and bending; thermodynamic stability and cellular expression) are essentially unchanged. This correlation between potency and lifetime suggests a mechanism of kinetic control. We propose that a locked DNA bend enables multiple additional rounds of transcriptional initiation per promoter. This model predicts the occurrence of a novel class of clinical variants, bent but unlocked HMG box-DNA complexes with native affinity and decreased lifetime. Aromatic DNA-intercalating agents exhibit analogous kinetic control of transcriptional elongation whereby chemotherapeutic potencies correlate with drug-DNA dissociation rates.",
author = "Etsuji Ukiyama and Agnes Jancso-Radek and Biaoru Li and Lukasz Milos and Wei Zhang and Phillips, {Nelson B.} and Nobuyuki Morikawa and King, {Chin Yen} and Ging Chan and Haqq, {Christopher M.} and Radek, {James T.} and Francis Poulat and Donahoe, {Patricia K.} and Weiss, {Michael A.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1210/mend.15.3.0621",
language = "English (US)",
volume = "15",
pages = "363--377",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - SRY and architectural gene regulation

T2 - The kinetic stability of a bent protein-DNA complex can regulate its transcriptional potency

AU - Ukiyama, Etsuji

AU - Jancso-Radek, Agnes

AU - Li, Biaoru

AU - Milos, Lukasz

AU - Zhang, Wei

AU - Phillips, Nelson B.

AU - Morikawa, Nobuyuki

AU - King, Chin Yen

AU - Chan, Ging

AU - Haqq, Christopher M.

AU - Radek, James T.

AU - Poulat, Francis

AU - Donahoe, Patricia K.

AU - Weiss, Michael A.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Protein-directed DNA bending is proposed to regulate assembly of higher-order DNA-multiprotein complexes (enhanceosomes and repressosomes). Because transcriptional initiation is a nonequilibrium process, gene expression may be modulated by the lifetime of such complexes. The human testis-determining factor SRY contains a specific DNA-bending motif, the high-mobility group (HMG) box, and is thus proposed to function as an architectural factor. Here, we test the hypothesis that the kinetic stability of a bent HMG box-DNA complex can in itself modulate transcriptional potency. Our studies employ a cotransfection assay in a mammalian gonadal cell line as a model for SRY-dependent transcriptional activation. Whereas sex-reversal mutations impair SRY-dependent gene expression, an activating substitution is identified that enhances SRY's potency by 4-fold. The substitution (l13F in the HMG box; fortuitously occurring in chimpanzees) affects the motif's cantilever side chain, which inserts between base pairs to disrupt base pairing. An aromatic F13 cantilever prolongs the lifetime of the DNA complex to an extent similar to its enhanced function. By contrast, equilibrium properties (specific DNA affinity, specificity, and bending; thermodynamic stability and cellular expression) are essentially unchanged. This correlation between potency and lifetime suggests a mechanism of kinetic control. We propose that a locked DNA bend enables multiple additional rounds of transcriptional initiation per promoter. This model predicts the occurrence of a novel class of clinical variants, bent but unlocked HMG box-DNA complexes with native affinity and decreased lifetime. Aromatic DNA-intercalating agents exhibit analogous kinetic control of transcriptional elongation whereby chemotherapeutic potencies correlate with drug-DNA dissociation rates.

AB - Protein-directed DNA bending is proposed to regulate assembly of higher-order DNA-multiprotein complexes (enhanceosomes and repressosomes). Because transcriptional initiation is a nonequilibrium process, gene expression may be modulated by the lifetime of such complexes. The human testis-determining factor SRY contains a specific DNA-bending motif, the high-mobility group (HMG) box, and is thus proposed to function as an architectural factor. Here, we test the hypothesis that the kinetic stability of a bent HMG box-DNA complex can in itself modulate transcriptional potency. Our studies employ a cotransfection assay in a mammalian gonadal cell line as a model for SRY-dependent transcriptional activation. Whereas sex-reversal mutations impair SRY-dependent gene expression, an activating substitution is identified that enhances SRY's potency by 4-fold. The substitution (l13F in the HMG box; fortuitously occurring in chimpanzees) affects the motif's cantilever side chain, which inserts between base pairs to disrupt base pairing. An aromatic F13 cantilever prolongs the lifetime of the DNA complex to an extent similar to its enhanced function. By contrast, equilibrium properties (specific DNA affinity, specificity, and bending; thermodynamic stability and cellular expression) are essentially unchanged. This correlation between potency and lifetime suggests a mechanism of kinetic control. We propose that a locked DNA bend enables multiple additional rounds of transcriptional initiation per promoter. This model predicts the occurrence of a novel class of clinical variants, bent but unlocked HMG box-DNA complexes with native affinity and decreased lifetime. Aromatic DNA-intercalating agents exhibit analogous kinetic control of transcriptional elongation whereby chemotherapeutic potencies correlate with drug-DNA dissociation rates.

UR - http://www.scopus.com/inward/record.url?scp=85047683884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047683884&partnerID=8YFLogxK

U2 - 10.1210/mend.15.3.0621

DO - 10.1210/mend.15.3.0621

M3 - Article

C2 - 11222738

AN - SCOPUS:85047683884

VL - 15

SP - 363

EP - 377

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 3

ER -